Bladder Cancer Advocacy Network

Recent papers from Bladder Cancer Advocacy Network

1. Patient-Reported Outcome Instruments in Non-Muscle-Invasive Bladder Cancer (NMIBC): A Systematic ReviewOncology and Therapy · 2026
2. Difficult conversations in bladder cancer survivorship: Integrating mental health and intimacy into routine urologic careBladder Cancer · 2026
3. Lipid-Rich Urothelial CarcinomaThe American Journal of Surgical Pathology · 2026
4. Giant Cell Urothelial CarcinomaThe American Journal of Surgical Pathology · 2026
5. Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1–2 of the Development ProcessEuropean Urology Oncology · 2026
6. Neoadjuvant Intravesical Therapy for Patients with Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.2026
7. A multidimensional nomogram integrating immune, inflammatory, and coagulation markers for personalized prognosis in bladder cancer.2026
8. Empowering Patients: The Role of Shared Treatment Decision-Making in Advanced Bladder Cancer—A PodcastAdvances in Therapy · 2026
9. 385P “Breathe to Live”: A lung cancer advocacy and community awareness campaign in Piwoyi, Abuja, NigeriaESMO Open · 2026
10. Incorporating the Patient Voice into Attribute and Level Selection for a Preference Study: A Qualitative Study in Non-Muscle Invasive Bladder CancerPatient · 2026
11. Neoadjuvant Systemic Therapy in Kidney and Bladder Cancer: Current Evidence and Emerging ParadigmsAmerican Society of Clinical Oncology Educational Book · 2026
12. Consensus guidance on early identification and management of peripheral neuropathy in patients with UC receiving enfortumab vedotin: A Delphi study.Journal of Clinical Oncology · 2026
13. Fostering inclusive language for genitourinary cancer research: A multi-stakeholder co-creation effort.Journal of Clinical Oncology · 2026
14. Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non–Muscle-Invasive Bladder CancerJournal of Clinical Oncology · 2025
15. Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancersCA A Cancer Journal for Clinicians · 2025
16. ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder CancerNew England Journal of Medicine · 2025
17. Clinicopathologic and Prognostic Features of Sarcomatoid Urothelial CarcinomaThe American Journal of Surgical Pathology · 2025
18. End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder CancerJournal of Clinical Oncology · 2025
19. A plain language summary of the TROPHY-U-01 study (Cohort 2): use of sacituzumab govitecan after immunotherapy in people with metastatic urothelial cancer who cannot take cisplatin-based chemotherapyFuture Oncology · 2025
20. Muscle-Invasive Bladder Cancer Treatment Selection in an Emerging Treatment Era: A Patient Preference StudyUrology · 2025